Literature DB >> 16722349

Bacterial pneumonia in the AIDS patients.

A K Salami1, P O Olatunji, P O Oluboyo, A A Akanbi, E A Fawibe.   

Abstract

OBJECTIVE: To determine the incidence, microbiological pattern and prognostic factor of bacterial pneumonia in AIDS patients. STUDY
DESIGN: Prospective study of AIDS patients from July 2001 to Dec 2002.
METHODOLOGY: Adults AIDS patients on HAART drugs that develop acute fever, cough with bronchial breathing or lung crepitations had diagnostic evaluation that included chest x-ray, paired sputum microscopy, culture and sensitivity, paired blood culture and haematological profiles including CD4' cell count.
RESULTS: Twenty-one patients (22.6%), 9 males and 12 females developed community acquired pneumonia during this 16-month period. Pneumonia was confirmed in 9 patients (42.9%), presumed in 4 (19%) and probable in 8 (38%). Streptococcus pneumoniae accounted for 22% of the cases when immunity was less impaired. Staplhylococcus aureus accounted for another 22 % while Klebsiella pneumoniae, Pseudomonas aeraginosa and Escherichial coli were isolated in 11% each when immunity was severely compromised. Fifteen patients (71.4%) were successfully treated with routine antibiotics. Six cases (28.6%) died. All had anaemia, leucopoenia and low CD4 cell count. Four (66.7%) of this had positive bacterial culture with bacteremia in three of them.
CONCLUSION: Bacterial pneumonia in HIV-infected patients has similar presentation to that in the general population, Staphylococcus aureus and gram-negative bacilli especially Klebsiella pneumoniae were seen in a good proportion of the cases. Outcome of treatment was poor in the presence of positive bacterial culture, anemia, leucopoenia and very low CD4+ lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16722349     DOI: 10.4314/wajm.v25i1.28236

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  8 in total

1.  Pseudomonas aeruginosa pili and flagella mediate distinct binding and signaling events at the apical and basolateral surface of airway epithelium.

Authors:  Iwona Bucior; Julia F Pielage; Joanne N Engel
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

2.  Aetiological spectrum of severe community-acquired pneumonia in HIV-positive patients from Pune, India.

Authors:  Arati Mane; Pankaj Gujar; Shraddha Gaikwad; Shilpa Bembalkar; Sanjay Gaikwad; Tilak Dhamgaye; Arun Risbud
Journal:  Indian J Med Res       Date:  2018-02       Impact factor: 2.375

3.  Species, Risk Factors, and Antimicrobial Susceptibility Profiles of Bacterial Isolates from HIV-Infected Patients Suspected to Have Pneumonia in Mekelle Zone, Tigray, Northern Ethiopia.

Authors:  Gebre Adhanom; Dawit Gebreegziabiher; Yemane Weldu; Araya Gebreyesus Wasihun; Tadele Araya; Haftom Legese; Bruno S Lopes; Muthupandian Saravanan
Journal:  Biomed Res Int       Date:  2019-05-05       Impact factor: 3.411

4.  Opportunistic Respiratory Infections in HIV Patients Attending Sukraraj Tropical and Infectious Diseases Hospital in Kathmandu, Nepal.

Authors:  Rooku Kc; Sadiksha Adhikari; Anup Bastola; Lina Devkota; Parmananda Bhandari; Prabina Ghimire; Bipin Adhikari; Komal Raj Rijal; Megha Raj Banjara; Prakash Ghimire
Journal:  HIV AIDS (Auckl)       Date:  2019-12-27

5.  Multiresistant Bacterial Pathogens Causing Bacterial Pneumonia and Analyses of Potential Risk Factors from Northeast Ethiopia.

Authors:  Tewodros Dessie; Mohabaw Jemal; Minwuyelet Maru; Moges Tiruneh
Journal:  Int J Microbiol       Date:  2021-03-08

6.  Chest X-ray findings in HIV- infected Highly Active Antiretroviral Treatment (HAART)-naïve patients.

Authors:  Akinsegun Akinbami; Babajide Balogun; Modupe Balogun; Owolabi Dosunmu; Olajumoke Oshinaike; Adewumi Adediran; Kayode Adegboyega
Journal:  Pan Afr Med J       Date:  2012-07-19

7.  Validating a novel index (SWAT-Bp) to predict mortality risk of community-acquired pneumonia in Malawi.

Authors:  Imogen M Buss; Edmund Birkhamshaw; Michael A Innes; Itai Magadoro; Peter I Waitt; Jamie Rylance
Journal:  Malawi Med J       Date:  2018-12       Impact factor: 0.875

8.  Repurposing of Ciclopirox to Overcome the Limitations of Zidovudine (Azidothymidine) against Multidrug-Resistant Gram-Negative Bacteria.

Authors:  Hyejin Cho; Kwang-Sun Kim
Journal:  Pharmaceutics       Date:  2022-03-01       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.